Pathios Therapeutics is a biotech company focused on the development of therapies for autoimmune diseases and cancer.
pathios therapeutics has raised €8.1M across 1 funding round, most recently a Series A round in Oct 2019. Based in Oxford, UK; founded 2017; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2019-10-01 | Series A | €8.1M |
| — |
| View deal → |
